Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfa677895183d3e8fbcc8254295f6b0c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0653 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0652 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0626 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0659 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-0663 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0601 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0603 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0613 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0624 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H01L27-15 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B21-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06 |
filingDate |
2016-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_812a58eb1f78df40f66950d188ed2e98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52eac0509e2686ae9fa54bc4ca900f3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f96442c0a6273c28980f844627da1975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe1d20fb47aab212e55ac688ded9cd26 |
publicationDate |
2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3328491-A1 |
titleOfInvention |
Systems and methods for phototherapeutic modulation of nitric oxide |
abstract |
Systems and methods for phototherapeutic modulation of nitric oxide in mammalian tissue include use of a first wavelength and first radiant flux of light to stimulate enzymatic generation of nitric oxide, and use of a second wavelength and second radiant flux of light to stimulate release of nitric oxide from endogenous stores of nitric oxide. Pulsed light and/or partially non-overlapping light impingement windows may be used. Non-coherent light impinged on tissue may include a peak wavelength in a range of from 410 nm to 440 nm in the absence of light emissions having a peak wavelength of from 600 nm to 900 nm. |
priorityDate |
2015-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |